Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-07

Clinical Trial Update: Combination of Equisetum Arvense and Palmitoylethanolamide (PEA) for the Management of Patients With Chronic Pain in a Before-after Study [Phase 1, Phase 2]

View source ↗

Summary

Before-after Phase 1/2 trial evaluating the combination of horsetail extract (Equisetum arvense) and palmitoylethanolamide (PEA) for chronic pain; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Equisetum arvense extract (Equisetum arvense)
  • Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: noiVita Srls | Conditions: Chronic Pain, Chronic Pain (Back / Neck) | Phase 1, Phase 2 | Status: COMPLETED